Grading Gottlieb: How Attys View FDA Chief's First 6 Months

Law360, New York (November 9, 2017, 10:18 PM EST) -- In Scott Gottlieb’s first six months as U.S. Food and Drug Administration chief, he has moved rapidly to streamline approvals and has become something of a rock-star regulator who tweets energetically about everything from gene therapy to skinny jeans.

Gottlieb, who was sworn in as FDA commissioner on May 11, has prioritized quicker approvals of prescription drugs and medical devices, including direct-to-consumer DNA tests and digital health software. In doing so, he has adopted a relatively freewheeling public posture — including an enthusiastic embrace of social...
To view the full article, register now.